BerGenBio ASA (BRRGF)
USD 2.31
(-7.6%)
USD 2.31
(-7.6%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17.11 Million USD | 0.7% |
| 2022 | 16.99 Million USD | -66.67% |
| 2021 | 50.99 Million USD | -40.86% |
| 2020 | 86.21 Million USD | 180.21% |
| 2019 | 30.76 Million USD | -29.67% |
| 2018 | 43.74 Million USD | -6.9% |
| 2017 | 46.98 Million USD | 131.74% |
| 2016 | 20.27 Million USD | 117.83% |
| 2015 | 9.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.51 Million USD | -22.31% |
| 2024 Q2 | 20.44 Million USD | 61.31% |
| 2023 Q1 | 8.17 Million USD | -51.92% |
| 2023 Q2 | 22.37 Million USD | 173.81% |
| 2023 FY | 17.11 Million USD | 0.7% |
| 2023 Q3 | 17.56 Million USD | -21.51% |
| 2023 Q4 | 17.11 Million USD | -2.55% |
| 2022 Q2 | 30.87 Million USD | -28.55% |
| 2022 FY | 16.99 Million USD | -66.67% |
| 2022 Q4 | 16.99 Million USD | -21.43% |
| 2022 Q3 | 21.62 Million USD | -29.93% |
| 2022 Q1 | 43.2 Million USD | -15.27% |
| 2021 Q1 | 78.86 Million USD | 0.0% |
| 2021 Q4 | 50.99 Million USD | -13.31% |
| 2021 Q3 | 58.82 Million USD | -13.44% |
| 2021 Q2 | 67.95 Million USD | -13.83% |
| 2021 FY | 50.99 Million USD | -40.86% |
| 2020 FY | 86.21 Million USD | 180.21% |
| 2019 FY | 30.76 Million USD | -29.67% |
| 2018 FY | 43.74 Million USD | -6.9% |
| 2017 FY | 46.98 Million USD | 131.74% |
| 2016 FY | 20.27 Million USD | 117.83% |
| 2015 FY | 9.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 10.55 Million USD | -62.169% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -774.039% |
| CSL Limited | 38.02 Billion USD | 99.955% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 86.856% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4740.078% |
| BioStem Technologies, Inc. | 14.56 Million USD | -17.548% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 67.524% |
| Qrons Inc. | 420.00 USD | -4074980.476% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2999.931% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 38.751% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 42.977% |
| Skye Bioscience, Inc. | 11.94 Million USD | -43.34% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -3461.563% |
| Rebus Holdings, Inc. | 5000.00 USD | -342206.76% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -2389.554% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -740823.723% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.495% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -2120.914% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 55.942% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -137.062% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -22315.771% |
| SQZ Biotechnologies Company | 107.18 Million USD | 84.032% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -1095.178% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -23551.403% |
| Mesoblast Limited | 667.9 Million USD | 97.437% |
| Marizyme, Inc. | 22.01 Million USD | 22.256% |
| Genus plc | 1.02 Billion USD | 98.337% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1160.007% |
| Pharming Group N.V. | 462.85 Million USD | 96.302% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -416.61% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -3329.659% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2629.719% |
| ContraFect Corporation | 20.67 Million USD | 17.233% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -4284.434% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -4378.38% |
| IMV Inc. | 31.33 Million USD | 45.377% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -312.813% |
| MultiCell Technologies, Inc. | 126.22 USD | -13559825.527% |
| ONE Bio Corp. | 70.08 Million USD | 75.579% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1721.383% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 86.682% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -3864.508% |
| Q BioMed Inc. | 3.51 Million USD | -386.851% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 51.348% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -6450.649% |
| Biomind Labs Inc. | 73.81 Thousand USD | -23085.546% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 96.165% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -1081.311% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -523.206% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -557.474% |
| GB Sciences, Inc. | 103.44 Thousand USD | -16445.831% |
| Alpha Cognition Inc. | 2.45 Million USD | -597.967% |
| HST Global, Inc. | 1526.00 USD | -1121481.782% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1632.38% |
| Halberd Corporation | 10.13 Thousand USD | -168840.263% |
| Enzolytics Inc. | 361.7 Million USD | 95.268% |
| Agentix Corp. | 261.39 Thousand USD | -6447.767% |
| Resverlogix Corp. | 8.11 Million USD | -110.91% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -811.418% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.623% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 64.12% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -2575.71% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -75029.88% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -91.251% |
| AVAX Technologies, Inc. | 7.37 Million USD | -132.005% |
| Zenith Capital Corp. | 7410.00 USD | -230876.221% |
| Ember Therapeutics, Inc. | 184.00 USD | -9301714.13% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -5218.527% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -6448.468% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1744.403% |
| Kadimastem Ltd | 2.3 Million USD | -642.827% |
| Helix BioMedix, Inc. | 3.02 Million USD | -465.78% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -29877.472% |
| LadRx Corporation | 2.3 Million USD | -641.604% |
| Cell Source, Inc. | 195.17 Thousand USD | -8669.406% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -4740.078% |
| NovAccess Global Inc. | 62.24 Thousand USD | -27395.402% |
| Affymax, Inc. | 7.44 Million USD | -129.952% |
| Itoco Inc. | 1.4 Million USD | -1122.461% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -17792.405% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -16046.545% |
| Mobile Lads Corp. | 52.00 USD | -32914011.538% |
| CytoDyn Inc. | 11.13 Million USD | -53.694% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -11871.112% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -95623.367% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -4340.11% |
| SYBLEU INC | 330.46 Thousand USD | -5079.121% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -4080.366% |
| International Stem Cell Corporation | 5.39 Million USD | -217.539% |
| Bioxytran, Inc. | 137.63 Thousand USD | -12335.038% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -14.088% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -3.235% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -21564.985% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1879.391% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -127.688% |
| Neutra Corp. | 2851.00 USD | -600227.534% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 47.185% |
| PureTech Health plc | 693.97 Million USD | 97.534% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -112.057% |
| IXICO plc | 15.84 Million USD | -8.025% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -106.657% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 83.435% |
| CSL Limited | 38.02 Billion USD | 99.955% |
| Cellectis S.A. | 333.99 Million USD | 94.876% |